4 pharmaceutical companies accused in the opioid epidemic reach a $260 million settlement just before trial
Hours before the first federal trial in the opioid epidemic was set to begin, four pharmaceutical companies reached a settlement totaling $260 million.
The four companies — McKesson Corp., Cardinal Health Inc., AmerisourceBergen Corp., and Teva Pharmaceutical Industries Ltd. — reached a settlement Monday morning with the two plaintiffs, Summit and Cuyahoga counties in Ohio.
McKesson Corp., Cardinal Health Inc., and AmerisourceBergen Corp. will pay out a combined $215 million immediately, and Teva Pharmaceutical will pay $20 million, officials said at a press conference Monday.
Teva will also be donating $25 million worth of Suboxone, according to a source familiar with the settlement.
The settlement was struck between midnight and 1 a.m. Monday and the case was dismissed with prejudice, US District Court Judge Dan Polster said.
The defendants were supposed to appear in a Cleveland court Monday in the first federal multidistrict litigation (MDL) trial involving the opioid epidemic. Thousands more plaintiffs’ cases are awaiting trial.
MDL is similar to class-action lawsuits in the sense that both consolidate plaintiffs’ pretrial proceedings, for the sake of efficiency. But unlike with class-action lawsuits, each plaintiff in an MDL case can get a different verdict or award.
The plaintiffs in this MDL case — Summit and Cuyahoga counties — were the first among more than 2,700 plaintiff communities to head to trial.
Attorneys general from four states — North Carolina, Tennessee, Pennsylvania, and Texas — lauded Monday’s settlement as “an important step” in combating the opioid epidemic.
“People in every corner of the country have been hurt by this crisis, and it is critical that settlement funds be distributed fairly across states, cities, and counties and used wisely to combat the crisis,” the attorneys general said in a joint statement.
“The global resolution we are working to finalize will accomplish those goals while also ensuring that these companies change their business practices to prevent a public health crisis like this from ever happening again.”
Two other defendants were also involved in this case — a smaller pharmaceutical company, Henry Schein Medical, and the pharmacy chain Walgreens.
Walgreens was not part of the settlement. Judge Polster said claims against the company have been cut off and moved to a different track, with a schedule to follow.
Walgreens released a statement Monday saying it is “completely unlike the wholesalers involved in the national opioid litigation.”
“Before 2014, Walgreens delivered opioid medications — among many other types of medications — only to our own pharmacies, staffed by our own pharmacy professionals,’ company spokesman Phil Caruso said.
Henry Schein Medical will be making a donation of $1 million to establish an educational foundation with Summit County and will pay $250,000 of the county’s expenses, the company said in a written statement.
Henry Schein said the plaintiffs have “agreed to dismiss the Company.”
The sudden settlement Monday followed marathon negotiations that went nowhere last week.
The talks lasted more than 10 hours and involved the CEOs of the four major companies; attorneys general from Tennessee, North Carolina, Pennsylvania and Texas’ and lawyers representing over 2,000 state, local, and Native American tribal governments.
Attorneys for the plaintiffs welcomed the settlement but said more work needs to be done in fighting the opioid epidemic.
“The proposed settlement will make significant progress to abate the epidemic by providing resources for and applying funds directly to necessary opioid-recovery programs,” said a joint statement from Paul J. Hanly Jr., Paul T. Farrell Jr., and Joe Rice.
“Throughout this process, Summit and Cuyahoga Counties have tirelessly investigated, litigated, and prepared for the bellwether trial that would have begun today if not for this agreement. In doing so, the communities revealed facts about the roles of the opioid industry that created and fueled the opioid epidemic.
Additionally, through the discovery process, we learned that this country’s pharmacy system has played a greater role in the opioid epidemic than previously realized. Cuyahoga and Summit will continue to litigate against pharmacy defendants to further understand the industry’s failings and potential wrongdoing.”